AngioDynamics (ANGO) Q1 2027 Earnings Call Transcript

AngioDynamics (ANGO) saw a 13.2% surge in its medtech segment, driven by record volumes of NanoKnife prostate procedures, as reported during its Q1 2027 earnings call.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.

Join Navvyx - it's Free